MeiraGTx
Maegan Little is a seasoned professional in the field of regulatory affairs and quality assurance, currently serving as Senior Manager of Regulatory Affairs at MeiraGTx since August 2022. With a strong background in the pharmaceutical industry, Maegan held similar roles at Abeona Therapeutics from April 2019 to April 2022, where responsibilities included both Senior Manager and Senior Specialist positions in Regulatory Affairs and Quality Assurance. Prior experience includes positions at Hikma Pharmaceuticals, where Maegan supervised Document Control and worked as a Scientific Writer, as well as roles at Boehringer Ingelheim focusing on NDA/ANDA and IP Product Acquisition Transfer. Maegan's early career involved freelance writing and editorial work, as well as legal assistance and document processing. Educational qualifications include a Master of Science in Regulatory Affairs from Northeastern University and a Bachelor of Arts in English from Shippensburg University of Pennsylvania, along with a Project Management Certificate from Kent State University.
This person is not in any offices
MeiraGTx
2 followers
MeiraGTx, a New York and London-based company, is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders.